ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.240
+0.070 (5.98%)
At close: Sep 1, 2026, 4:00 PM EDT
1.230
-0.010 (-0.81%)
After-hours: Sep 1, 2026, 7:30 PM EDT
ADC Therapeutics Employees
As of December 31, 2025, ADC Therapeutics had 193 total employees, including 188 full-time and 5 part-time employees. The number of employees decreased by 72 or -27.17% compared to the previous year.
Employees
193
Change (1Y)
-72
Growth (1Y)
-27.17%
Revenue / Employee
$412,352
Profits / Employee
-$502,114
Market Cap
158.31M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 193 | -72 | -27.17% | 188 | 5 |
| Dec 31, 2024 | 265 | -9 | -3.28% | 263 | 2 |
| Dec 31, 2023 | 274 | -43 | -13.56% | 273 | 1 |
| Dec 31, 2022 | 317 | 5 | 1.60% | 317 | 0 |
| Dec 31, 2021 | 312 | 104 | 50.00% | 312 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,120 |
| Aurora Cannabis | 1,028 |
| Organogenesis Holdings | 854 |
| Lifecore Biomedical | 382 |
| Anika Therapeutics | 235 |
| Akebia Therapeutics | 194 |
| Cumberland Pharmaceuticals | 88 |
| Journey Medical | 58 |
ADCT News
- 15 days ago - ADC Therapeutics price target lowered to $5 from $10 at Guggenheim - TheFly
- 15 days ago - ADC Therapeutics reports Q2 adjusted EPS (11c) vs. (25c) last year - TheFly
- 19 days ago - ADC Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 19 days ago - ADC Therapeutics Earnings release: Q2 2026 - Filings
- 19 days ago - ADC Therapeutics Slides: Q2 2026 - Filings
- 19 days ago - ADC Therapeutics Earnings release: Q2 2026 - Filings
- 19 days ago - ADC Therapeutics Quarterly report: Q2 2026 - Filings
- 19 days ago - ADC Therapeutics Slides: Corporate presentation - Filings